Učitavanje...
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
Triple negative breast cancer (TNBC) is an aggressive breast cancer with historically poor outcomes, primarily due to the lack of effective targeted therapies. The tumor molecular heterogeneity of TNBC has been well recognized, yet molecular subtype driven therapy remains lacking. While neoadjuvant...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2020-05-01
|
| Serija: | Cancers |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2072-6694/12/6/1404 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|